Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors:
  • Weissman, Neil J
PMID:
  • 30145941
Year: 2018
Citation:
  • New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD
DOI:
Add to cart
2.
Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 23661689
Year: 2013
Citation:
  • Circulation. Cardiovascular imaging. 6(4):560-7, 2013 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Koch GG, Sanchez M, Shanahan WR, Smith SR, Weissman NJ
DOI:
Add to cart
Pages

Powered by Koha